In particular, triple-negative breast cancer (TNBC) sub-type that lacks the expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor (HER2)6 is associated with a 4-fold increased risk of distant metastasis and shorter overall survival7. This evidence concerns the gene PGR and triple-negative breast carcinoma.